Neurocrine Biosciences (NBIX) Sales of Property, Plant and Equipment (2010 - 2019)
Powered by 
Analysis
Neurocrine Biosciences (NBIX) Sales of Property, Plant and Equipment (2010 - 2019) Analysis & Trends
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Sales of Property, Plant and Equipment (Qtr) |
|---|---|---|---|---|---|
| 1 | Johnson & Johnson | 646.10 Bn | 625.34 Bn | 17.26 Bn | 63.00 Mn |
| 2 | AbbVie | 441.68 Bn | 435.11 Bn | 12.70 Bn | - |
| 3 | Merck | 366.62 Bn | 359.48 Bn | 12.21 Bn | - |
| 4 | Novartis Ag | 266.55 Bn | 258.86 Bn | 11.24 Bn | 26.00 Mn |
| 5 | Pfizer | 159.14 Bn | 147.45 Bn | 10.94 Bn | - |
| 6 | Sanofi | 52.40 Bn | 45.02 Bn | 10.79 Bn | 363.82 Mn |
| 7 | Revolution Medicines | 44.07 Bn | 44.07 Bn | - | - |
| 8 | Incyte | 25.59 Bn | 21.05 Bn | 1.57 Bn | - |
| 9 | United Therapeutics | 21.54 Bn | 18.88 Bn | 683.80 Mn | - |
| 10 | Neurocrine Biosciences | 15.60 Bn | 15.21 Bn | 935.80 Mn | - |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Sep 30, 2019 | 4,000.00 |
| Mar 31, 2019 | 4,000.00 |
| Dec 31, 2018 | 4,000.00 |
| Jun 30, 2018 | 12,000.00 |
| Mar 31, 2018 | 18,000.00 |
| Sep 30, 2017 | 7,000.00 |
| Jun 30, 2016 | 10,000.00 |
| Mar 31, 2016 | 3,000.00 |
| Mar 31, 2015 | 9,000.00 |
| Jun 30, 2014 | 5,000.00 |
| Mar 31, 2014 | 40,000.00 |
| Dec 31, 2013 | 2,000.00 |
| Sep 30, 2013 | 38,000.00 |
| Jun 30, 2013 | -13,000.00 |
| Mar 31, 2013 | 13,000.00 |
| Dec 31, 2012 | 7,000.00 |
| Sep 30, 2012 | 53,000.00 |
| Jun 30, 2012 | -53,000.00 |
| Mar 31, 2012 | 25,000.00 |
| Dec 31, 2011 | 58,000.00 |